Companies sponsors |
Johnson and Johnson (amivantamab) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Asthma and Lung UK |
|
Black Health Agency for Equality |
|
Cancer Black Care |
|
Cancer Equality |
|
Cancer52 |
|
EGFR Positive UK |
|
Helen Rollason Cancer Charity |
|
Independent Cancer Patients Voice |
|
Macmillan Cancer Support |
|
Maggie’s Centres |
|
Marie Curie |
|
NARA – The Breathing Charity |
|
Oncogene-Driven Lung Cancer Patient Alliance UK |
|
Roy Castle Lung Cancer Foundation |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
|
Tenovus Cancer Care |
|
UK Lung Cancer Coalition |
Professional groups |
Association for Respiratory Technology and Physiology |
|
Association of Anaesthetists |
|
Association of Cancer Physicians |
|
Association of Respiratory Nurse Specialists |
|
Association of Surgeons of Great Britain and Ireland |
|
British Geriatrics Society |
|
British Institute of Radiology |
|
British Oncology Pharmacy Association |
|
British Psychosocial Oncology Society |
|
British Rhinological Society |
|
British Society of Interventional Radiology |
|
British Thoracic Oncology Group |
|
British Thoracic Society |
|
British Transplantation Society |
|
Cancer Research UK |
|
ILD-IN: Interstitial Lung Diseases Interdisciplinary Network |
|
Lung Cancer and Mesothelioma Clinical Expert Group |
|
Lung Cancer Nursing UK |
|
National Heart and Lung Institute |
|
NHS Blood and Transplant |
|
Primary Care Respiratory Society |
|
Royal College of Anaesthetists |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal College of Radiologists |
|
Royal College of Surgeons |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
Society and College of Radiographers |
|
UK Clinical Pharmacy Association |
|
UK Oncology Nursing Society |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
Amarox (erlotinib) |
|
Aspire pharma (pemetrexed) |
|
AstraZeneca (gefitinib, osimertinib) |
|
Boehringer Ingelheim (afatinib) |
|
Bristol Myers Squibb (paclitaxel) |
|
Cipla EU (gefitinib) |
|
Eli Lilly and company (pemetrexed) |
|
Genus pharmaceuticals (pemetrexed, gefitinib) |
|
Glenmark Pharmaceutical (erlotinib) |
|
Hospira UK (carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel) |
|
Medac GmbH (vinorelbine) |
|
Merck, Sharp & Dohme (pembrolizumab) |
|
Mylan (erlotinib) |
|
Pfizer (pemetrexed, dacomitinib) |
|
Pierre Fabre (vinorelbine) |
|
Roche (atezolizumab, erlotinib) |
|
Sandoz (cisplatin, docetaxel, pemetrexed, erlotinib, gefitinib) |
|
Seacross pharmaceuticals (docetaxel, paclitaxel, pemetrexed) |
|
Sun Pharmaceuticals (gemcitabine, pemetrexed) |
|
Synchrony Pharma (gemcitabine) |
|
Teva UK (paclitaxel) |
|
Zentiva (pemetrexed, erlotinib) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Department of Health – Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
NHS Alliance |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
British Association for Lung Research |
|
Cochrane Airways Group |
|
Cochrane Lung Cancer Group |
|
Cochrane UK |
|
Genomics England |
|
Institute of Cancer Research |
|
MRC Clinical Trials Unit |
|
National Institute for Health Research |